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Abstract: 
Background:  
Rotator cuff tendinopathies present as one of the most common musculoskeletal injuries 
of the upper extremity. The rotator cuff consists of four muscles: the supraspinatus, infraspinatus, 
teres minor, and subscapularis with the supraspinatus the most injured of the group. Over time, 
variations regarding treatment through surgical or nonsurgical interventions have remained 
constant. In recent years, the use of platelet-rich plasma (PRP) as an additional alternative has 
become popular to promote healing and improve functionality of the shoulder. The purpose of 
this clinical review using various study designs is to assess if the platelet-rich plasma injections 
are more effective when used with traditional surgical or nonsurgical interventions for the long-
term outcomes of adult patients with rotator cuff tendinopathies. 
Methods:  
A systematic database search was conducted for peer-reviewed articles and studies dated 
from 2018 to present using Google Scholar, PubMed, and ScienceDirect. Information pertinent 
to this clinical review consisted of 20 articles allowing for an all-encompassing comparative 
foundation to determine the most effective long-term treatment for rotator cuff tendinopathies. 
CURRENT Medical Diagnosis & Treatment was also used. 
Conclusion:  
After evaluating all of the data collected to determine if platelet-rich plasma is effective 
in improving pain, range of motion, and functionality for patients with rotator cuff 
tendinopathies, results widely varied. At this time, it seems as if more research needs to be 
conducted because although it has been proven to show improvements, there are still variable 
results for both pre and post-operative intervention use of PRP.. 
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Introduction: 
The shoulder is the most mobile large joint in the human body and because of this, it is 
going to be prone for injury, which is commonly associated with the rotator cuff muscles. The 
rotator cuff is composed of 4 major muscles: the supraspinatus, infraspinatus, teres minor, and 
subscapularis.1 These muscles together promote stability of the shoulder while also allowing for 
major movements of the upper extremity. The supraspinatus originates at the supraspinous fossa 
of the scapula and inserts onto the greater tuberosity of the humerus. Both the infraspinatus and 
teres minor originate at the infraspinous process of the scapula and insert at the greater tuberosity 
of the humerus. The subscapularis originates at the subscapular fossa and inserts at the lesser 
tuberosity of the humerus.1 Due to the structure in which these muscles exist in the shoulder, the 
supraspinatus tends to be the most likely to experience tendinopathies. 
There are many causes in which one may experience rotator cuff tendinopathies: 
structural abnormalities such as a downward sloping acromion causing an impingement of the 
suprascapular nerve, age related degenerative processes that weaken the muscle and tendon, or 
biomechanical factors such as tensile overload in external rotation, abduction, and extension of 
the humerus.2 It is quite common to see such injuries in sports heavily involved in the use of 
overhead movements such as baseball, tennis, and football with the most significant being a full 
thickness rotator cuff tear. When a full thickness rotator cuff tear takes place typically occurring 
in the supraspinatus, the patient will lose structural integrity of the shoulder. If structural 
integrity is compromised, a superior subluxation of the humeral head will force the intact portion 
of the supraspinatus to move anteriorly with infraspinatus moving posteriorly.2 This will cause 
pain and loss of functionality of the shoulder for the patient with standard overhead movements 
due to not only the tear but now the presence of a possible impingement. A systematic review 
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and meta-analysis published in the Journal of Rehabilitation Medicine by Leong et al to 
determine the major risk factors for rotator cuff tendinopathies. The data was retrieved from 16 
different studies with patients presenting with various conditions such as rotator cuff 
tendinopathies, shoulder impingements, and subacromial bursitis. What they found was that an 
age > 50 years, diabetes, and overhead activities were the most common risk factors associated 
with developing rotator cuff tendinopathies and shoulder injuries.3 For management of pain and 
to improve functionality of the shoulder, there are both surgical and nonsurgical options for the 
patient. 
         Traditional nonsurgical and surgical interventions have remained the standard of care for 
years regarding the treatment of rotator cuff tendinopathies. Many surgeons advocate for 
nonsurgical methods prior to surgery to determine if there is a possibility for pain reduction and 
improvement of functionality while being as minimally invasive as possible. Options for 
traditional nonsurgical interventions consist of physical therapy, non-steroidal anti-inflammatory 
medications, corticosteroid injections, and nerve blocks/ablations.4 If these interventions fail, 
surgical interventions are typically the next step in treatment. 
         Platelet-rich plasma (PRP) injections have become a regularly used alternative to 
traditional surgical and nonsurgical interventions in rotator cuff tendinopathies. It is injected into 
the injured shoulder, typically guided by ultrasound, to promote healing of the damaged rotator 
cuff. The platelet-rich plasma is used because the high concentrations of platelets promote the 
release of growth factors in the tissue leading to regeneration and improved healing while being 
much less invasive than surgical interventions.5  
Rotator cuff tendinopathies have become increasingly more common and treatment 
methods continue to evolve. The aim of this clinical review is to assess if platelet-rich plasma 
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injections prove to be more beneficial in long-term outcomes compared to traditional surgical 
and nonsurgical interventions for pain, range of motion, and functionality in adult populations. 
Each study design has specific measurements to assess these factors utilizing physical 
characteristics, self-evaluation surveys, and imaging. As monotherapy, it is hypothesized that 
PRP will show to be better in the short-term for pain, range of motion, and functionality with 
surgery being more beneficial in the long-term. As combo therapy, it is also hypothesized that 
the use of PRP and surgery together will be the most effective for overall long-term health due to 
the immediate interventions of surgery and healing factors of the platelet-rich plasma to decrease 
pain, and improve range of motion and functionality. 
Background: 
Surgical intervention: 
Of the common modalities for rotator cuff tendinopathies, surgical interventions remain 
popular for medium thickness to full thickness tears or acromion structural abnormalities. 
Surgery is typically used due to the persistent symptoms and functional impairment limiting a 
patient after nonsurgical interventions have failed.  
These surgical interventions for rotator cuff tendinopathies allow for patients the 
opportunity to accelerate the healing process and improve limitations. Though some surgeons are 
interested in providing nonsurgical interventions to alleviate and improve symptoms prior to 
performing surgery, others believe that surgery is the intervention of choice because of the 
immediate repair. Surgery is most performed arthroscopically where surgeons use the double-
row technique to properly anchor the rotator cuff tear to the humerus while also executing and 
debridement necessary to promote healing and functionality.14 Diagram of the procedure can be 
found in the appendix under image 1.6 
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A review of surgical techniques, animal models, and new technologies currently under 
development was published in the Journal of Shoulder and Elbow Surgery by Deprés-Tremblay 
et al. Various arthroscopic and open surgical techniques exist for the repair of rotator cuff 
tendinopathies: transosseous equivalent repair (TOE), single row suture anchor, or double row 
suture anchor.6 The double row shows the greatest rate of improvement in tendon healing, but all 
interventions discussed have been shown to be effective. In a comprehensive review of 
arthroscopic double row rotator cuff repairs from Aydin et al., the double row technique is 
described as two rows of anchors, one medial and one lateral, passed through the torn rotator cuff 
and into greater tuberosity of the humerus securing the damaged tissue back in its anatomically 
correct position.7 By doing so, without too much tension applied, the tendon can regenerate, and 
biomechanical function can be restored because structural integrity of the shoulder is restored. 
Surgical interventions do not come without financial implications. It has previously been 
stated that the average cost of a rotator cuff repair is between $6374 and $13,270, thought to be 
more cost effective than nonsurgical management saving the United States $3.44 billion 
annually.8 In the Journal of Shoulder and Elbow Surgery, an analysis of 40,618 rotator cuff 
repairs was conducted by Li et al to assess the primary cost drivers of the procedure.8 With the 
reported number of rotator cuff repairs at 250,000+ in the United States annually, understanding 
the dynamics of cost is essential in selecting a course of interventions. This study using the State 
and Ambulatory Surgery and Services Databases (SASD) analyzed patient and surgical 
contributions from 6 states to the overall cost of rotator cuff surgery. By considering factors such 
as demographics, income, comorbidities, and insurance provider along with the surgical factors 
such as anchors, anesthesia, and subacromial decompression, a true representation of cost can be 
demonstrated. Of the cases analyzed, it was determined that the average cost was $25,353 but 
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had a significant standard deviation of $16,747 depending on state. With subacromial 
decompression adding $4992 and the cost of each anchor being $1249, there are major cost 
drivers that need to be considered when performing surgery.8 
When truly assessing the success of a treatment modality, long-term outcomes regarding 
functionality and reduction in limitations should be greatly considered. In Revista Brasileira de 
Ortopedia, Miyazaki et al conducted a study by evaluating patients who received arthroscopic 
rotator cuff surgery for massive rotator cuff tears and evaluated their improvements or 
limitations in functionality. Originally in 2006, there were 61 patients who participated in the 
study and 89% of them reported good to excellent results according to the UCLA criteria for 
functionality.9 But the results they were looking for were more specific to long-term outcomes, 
so they also went on to follow-up a minimum of 8-years later beginning in 2014 at the earliest. In 
that subsequent evaluation, only 35 patients were eligible for follow-up with 15 not being able to 
be located, one refusing to participate, and two lost to death. Observing lateral and medial range 
of motion as well as elevation, 91% of patients reported good to excellent results. Re-injury was 
reported in 3 of the 35 cases.9 It remains important to note that though there was a significant 
loss in participation for follow-up, the remaining group showed very positive outcomes 
regarding functionality and range of motion post-arthroscopy for the rotator cuff repair. 
In a similar study, The American Journal of Sports Medicine also published a study by 
Randelli et al to determine the long-term results of arthroscopic rotator cuff surgery 10-years 
post-operation. In total, 169 patients were enrolled in the study where 149 completed the 
telephone portion and only a total of 102 were able to fulfill the final evaluation.10 The true goal 
was to assess if the patient’s 10-years post-operation intact supraspinatus tendon, integrity of the 
tendon, and functional and radiological outcomes. When the patient reached the 10-year mark, 
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they received a phone call to see if they had undergone reoperation to collect Simple Assessment 
Numeric Evaluation, Numeric Rating Scale, American Shoulder and Elbow Surgeons, and 
Simple Shoulder Test scores.  
After these scores were collected, they were invited for a follow-up visit to complete the 
Constant-Murley Score (CMS) to assess strength in forward flexion and abduction. Then 
followed the radiograph and ultrasound assessments to visualize the structural integrity of the 
shoulder. When analyzing the data, one critical concern that was noted included the size of the 
initial tear. Those who had larger initial tears had 2.18-higher risk to present with a non intact 
rotator cuff.10 These patients also showed a slight difference in CMS but nothing significant to 
note. One other remarkable finding was only about 50% of these patients evaluated still had an 
intact rotator cuff.10 Those who did still have their rotator cuff still intact reported higher 
functional outcomes, satisfaction, and reduced progression of osteoarthritis shown on radiograph. 
Refer to table 1 of study for statistical analysis.10 It is difficult to directly correlate the original 
significance of the rotator cuff tear to the long-term outcome because there was no follow-up in-
between, not enough predictive factors assessed, and these patients were not observed prior to 
their operation all in which could have contributed to failure of the rotator cuff repair. But when 
analyzing the initial size of the tear, results of this study show a significant correlation to 
outcomes.  
Traditional nonsurgical interventions: 
Typically, before navigating options of surgical interventions for rotator cuff 
tendinopathies, nonsurgical options are fully utilized. It has been shown that these are viable 
options to identify if improvements can be made to increase functionality of the upper extremity 
and decrease discomfort associated with the injury. The standard of care for traditional 
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nonsurgical interventions centers around options such as physical therapy, non-steroidal anti-
inflammatory medications, corticosteroid injections, and nerve blocks/ablations.4 With rotator 
cuff tendinopathies being the most common cause of pain and loss of function in the shoulder, 
nonsurgical interventions are important in a first-line attempt at rehabilitating the injury. Since 
the duty of the rotator cuff is not only to provide shoulder movement and function but also 
stability, it is important to strengthen and regain that stability to properly promote healing so the 
patient can regain function. 
Physical therapy is targeted to regain function while improving strength of muscles 
around the rotator cuff and improving flexibility. By doing so, improvements of biomechanical 
function can be made to improve healing and decrease likelihood for reinjury.4 Non-steroidal 
anti-inflammatory medications are a mainstay for pain management.4 Corticosteroid injections 
work efficiently in reducing inflammation and pain allowing for improved functionality.4 It is 
common for patients to receive these as polytherapy increasing their overall likelihood for 
greater long-term outcomes. The nerve blocks/ablations are reserved for patients who have not 
shown improvement with other nonsurgical interventions and are also not a candidate for 
surgery.4 
In most cases, surgeons will opt for nonsurgical management of these injuries first if the 
injury is not severely symptomatic after an acute injury. It is important to understand the injury 
itself before prescribing treatment such as thickness of the tear, acute or long-standing injury, age 
of the patient, previous operation, etc. Aboelmagd et al evaluated traditional nonsurgical options 
for treatment in eligible patients with rotator cuff injuries. Physiotherapy was the first in which 
they assessed. The complete picture of the patient and injury is important in the management and 
treatment of tendinopathies. Factors such as strengthening muscles around the joint, improving 
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posture, and improving biomechanical axis allowing for improved function will determine level 
of importance for each patient. In two studies included in this paper, using physiotherapy as 
initial management showed a success rate ranging from 75-91% in patients who suffered a 
rotator cuff tear regarding functionality and strengthening of the joint.4 Non-steroidal anti-
inflammatory medications were also used in such patients. Though deemed successful in the 
short term for pain relief, the NSAIDs were not studied extensively in the long term, mainly 
because other interventions were needed and they do not specifically promote healing as the 
alternatives would.  
In addition to physiotherapy and NSAIDs, corticosteroid injections have remained a 
mainstay in rotator cuff tendinopathy management for years. Used for both diagnostic and 
therapeutic treatment, they are used to reduce inflammation allowing patients to continue their 
physiotherapy program. But very similarly to the NSAIDs, the corticosteroids show a reduction 
in short term pain and increased functionality at 6 weeks but limit long term effect. Penning et al 
concluded that at 26 weeks, 21% of patients that received a placebo injection showed a reduction 
in pain compared to the 20% who received corticosteroid injections.11 Pain scores were assessed 
using the visual analogue score (VAS) to give a standard associated with the patient’s baseline. 
The scale is used as a measurement tool to help measure characteristics that may not be directly 
measurable, such as pain. Ultimately, the injections become serial so cost then becomes 
something to take into account.  
When patients suffer from end stage rotator cuff tendinopathies, are not eligible for 
surgical interventions, and have exhausted all other options, nerve blocks/ablations can be used. 
This treatment method is used mainly as pain management since there is no promotion of healing 
in the area. The suprascapular nerve is the targeted nerve as it supplies sensation to the shoulder 
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capsule.4 Kane et al demonstrated that the ablation of the nerve reduced pain up to 6 months 
according to VAS, Constant score, and Oxford score. 
When implementing traditional nonsurgical interventions to treat rotator cuff 
tendinopathies, it is vital to assess pain and functionality to determine success of the treatment 
for patients. In an article by Bush et al published in the World Journal of Orthopedics, a cohort 
of 59 patients with full-thickness rotator cuff tears confirmed by MRI or ultrasound were treated 
with nonsurgical interventions such as physical therapy and NSAIDs and had a follow-up at 6 
months and then a year and annually after that to identify the clinical significance of their 
progress.12 These patients were required to provide basic patient demographics, comorbidities, 
smoking status, and previous injury status all while partaking in the prescribed physical therapy 
program. Their program consisted of stretching, resistance band strengthening, and scapular 
stabilization exercises. They were assessed at baseline and each subsequent follow-up using the 
Western Ontario Rotator Cuff (WORC) index, American Shoulder, and Elbow Surgeons score, 
Visual Analog Scale, and Single Assessment Numerical Evaluation with the WORC score being 
the primary assessment tool.12 Specifically, the WORC score is developed based on a 
questionnaire the patient fills out to determine their pain and limitations associated with their 
rotator cuff tendinopathy.  
In the case of this study, with the use of nonsurgical interventions, all patients reported 
improvement from their baseline evaluation with no significant changes from one to two years.12 
Regressions in scores were associated with the female gender, smoking, and advanced 
subscapularis fatty infiltrations. The baseline WORC score was 46.05 with a standard deviation 
of 21.61. At the final follow-up (either one or two years after baseline was established) the score 
was 63.58 with a standard deviation of 25.6 showing an improvement of 17.53 from baseline.12 
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With pain being quite subjective, the general improvement regarding pain and functionality in 
this study in all participants is important in validating how nonsurgical interventions can improve 
patient outcomes in the short to intermediate timeline. 
Platelet-rich Plasma Injections: 
As the treatment for rotator cuff tendinopathies has evolved, alternatives to surgery and 
the traditional nonsurgical modalities have developed. Platelet-rich plasma (PRP) has become 
one of the most popular and most researched in recent years. It is a biologic solution containing 
high platelet concentrations which release growth factors to promote healing in torn tendons of 
the rotator cuff. By injecting into the injured shoulder, the healing process is enhanced allowing 
for more rapid regeneration of the tissue. The injection is typically aided by ultrasound to 
increase accuracy. 
Published in The Egyptian Rheumatologist, Ibrahim et al conducted a study comparing 
PRP to corticosteroid injections for rotator cuff tendinopathies and their effects on shoulder pain, 
disability, range of motion (ROM), and healing observed by ultrasound.6 The patient population 
consisted of 30 people from 23-66 years with rotator cuff tendinopathies of varying degrees 
assigned to two groups split evenly: 15 assigned to PRP treatment and 15 assigned to 
corticosteroid treatment. Pain was evaluated using the Visual Analogue Scale (VAS), ROM was 
measured using goniometer, functionality/disability was measured using the Shoulder Disability 
Questionnaire (SDQ), and specific rotator cuff tests such as the empty-can for supraspinatus, 
external rotation lag for infraspinatus, lift-off of subscapularis, and horn-blower sign for teres 
minor were also used. Patients were assessed at time of injection and then participated in a 7-
week exercise program and then assessed again at the 2-month mark. According to the findings, 
both PRP and corticosteroid injections showed great improvement for improvement of pain, 
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ROM and disability/functionality of the shoulder.5 There were no significant differences in the 
measurable findings. Regarding the ultrasound findings, PRP promoted slightly better healing 
and also presented a lesser likelihood in developing tendinitis and bursitis compared to 
corticosteroids.5 
Similarly to the above study, the Journal of Orthopaedic Surgery and Research by 
Dadgostar et al published a study comparing corticosteroids to PRP in the treatment and 
management of rotator cuff tendinopathies. A total of 58 patients were in the study evaluating 
pain with VAS as the primary assessment point with range of motion, WORC score, DASH 
score, and supraspinatus thickness also analyzed. Not discussed in previous studies, the DASH 
score is a 30-question questionnaire used to self-report physical function and symptoms a patient 
may be experiencing specific to the upper extremity. Patients were evaluated at baseline, one 
week, one month, and 3 months. The difference between this study compared to the previous 
study is that Dadgostar et al came to the conclusion that the PRP group showed significant 
improvement in VAS and ROM at 3 months compared to the corticosteroid group.13 Other 
statistical outputs remained similar and were not statistically relevant denoting any differences. 
The baseline and 3-month VAS and ROM scores have been attached as table 2 and 3 in the 
appendix.13 Though many results provided similar statistical improvements, the improvements in 
VAS and ROM express that PRP may be a viable option in pre-surgical management of rotator 
cuff tendinopathies in substitute for corticosteroids. 
An alternative study published in the Journal of Orthopaedic Surgery and Research by 
Kim et al studied the differences in outcomes of individuals with rotator cuff tendinopathies 
using PRP and general physical therapy modalities.14 The main objective of this study was to 
determine the importance of the cellular component of PRP compared to the importance of 
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regaining function and strength using physical therapy. Patients were required to be 18 years of 
age, needed a rotator cuff tendinopathy confirmed by ultrasound, no prior rotator cuff surgery or 
on any medications such as NSAIDs or steroid injections, and no presence of infection. A total of 
30 patients were divided into two groups: the PRP group who received a 2ml injection and the 
exercise group who took part in strengthening programs for the rotator cuff. The majority of the 
exercise program consisted of scapular stabilization as well as infraspinatus and subscapularis 
strengthening using isometric and isotonic exercise with dumbbells and Thera-bands. Patients 
were asked to perform their exercises for 20 minutes 4 times per week. Follow-up assessments 
were performed at 6, 12, and 24 weeks using the American Shoulder and Elbow Surgeons 
(ASES), Constant-Murley score, and numeric rating scale (NRS) all to assess pain and 
functionality while also using ultrasound to determine thickness and integrity of the rotator cuff. 
For the PRP group, growth factors were also measured due to the promotion PRP has on growth 
factors and healing.  
Regarding outcomes, of the 30 patients recruited, 8 of the 15 in the PRP group and 7 of 
the 15 in the exercise group did not complete their full 24-month follow-up. One of the 
significant findings was the 24-week ASES score after linear regression as it was much improved 
for the PRP group compared to the exercise group.14 For the PRP group, there was a change from 
42.8 with a standard deviation of 18.4 to 68.0 with a standard deviation of 23.8. The control 
group started at a baseline of 59.0 with a standard deviation of 13.4 and improved to 79.7 with a 
standard deviation of 14.1.14 The exercise group also expressed thicker supraspinatus on 
ultrasound.14 When measuring growth factors, the PRP group showed a higher amount present 
allowing for a greater environment to promote healing. Limitations with this study are a small 
sample size due to dropout rates and also the duration only being 24 weeks. 
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Continuing with the comparisons to PRP, Lin et al conducted a meta-analysis study 
comparing PRP to sham injections, no injections, or physiotherapy in MDPI.15 Very similar to 
the previous study by Kim et al, patients were assessed at 3-6, 12, and 24 weeks to determine the 
effectiveness of treatment on pain reduction (primary outcome) and functional improvement 
(secondary outcome). They also went about incorporating patients strictly with similar rotator 
cuff tendinopathies such as tendinosis, partial tears, and impingements and excluded full-
thickness tears, trauma, calcific rotator cuff disease, and rheumatological disease. By doing so, 
patients that were more likely candidates for surgery would not skew data. Of the patients 
included, the average age was 39.9 to 59.7 years where the tendinopathy needed to be confirmed 
by ultrasound or MRI. Differences were much more prominent in this meta-analysis compared to 
the small study performed by Kim et al. using similar assessment tools such as ASES, VAS, 
ROM, etc. In the short-term and medium-term follow-ups at 3-6 and 12 weeks, pain reduction 
differences were quite minimal, only showing substantial changes at the 24-week follow-up after 
heterogeneity was eliminated.15 Although the control group had three subgroups consisting of the 
sham injections, dry needling, and physiotherapy, no significant differences were noted 
comparing each one to the PRP. Regarding functional improvements, PRP showed slightly better 
results in short, medium, and long-term evaluations but nothing significant to choose one 
treatment’s realm over another.15 
In another systematic review and meta-analysis published in PLoS ONE performed by 
Hamid et al, 8 studies were reviewed to determine the effectiveness of platelet-rich plasma in 
long-term pain control and shoulder function in patients with rotator cuff tendinopathies.16 In 
total, there were 976 participants. The control varied; 4 incorporated normal saline injections and 
the other 4 utilized rehabilitation programs and dry needling. Very similarly to the last two 
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studies, these patients also required MRI or ultrasound diagnosis in order to be eligible for 
participation. The importance of the inclusion of this study is that it includes a lot of data with 
varying follow-ups ranging from 2-months to 2-years. The patient sample size consisted of those 
18-70 years-old where they were assessed using similar tools, again, such as ASES, WORC, 
SPADI, VAS, DASH, ROM, etc. to determine shoulder pain, ROM, and functionality in 
comparison to their baseline prior to treatment. Due to the extreme wide variety of assessment 
tools, it adds quite a bit of variation in the results.  
According to this meta-analysis, there were no significant differences in VAS pain scores 
between the PRP group and control groups in the short term when assessed at 3 weeks.16 
However at the medium and long-term follow-up assessments taking place at 6 and 12 months, 
the PRP group showed significantly less pain symptoms compared to the control.16 When 
assessing the SPADI scores for functionality, though, there is no specific correlation to the pain 
scores. The PRP group showed better results at 3 weeks, 3 months, and 6 months compared to 
the control.16 This study is able to support the idea that PRP is safe and effective for intermediate 
and even long-term shoulder pain and functionality for those with rotator cuff tendinopathies 
compared to traditional nonsurgical interventions but there were many limitations. There were 
too many variations in studies being compared and even too many assessment tools being used to 
not allow for much consistency. Regarding trends, though, it does follow what was previous 
thought and has many foundations that help support PRP. 
Platelet-rich Plasma and Surgery: 
As discussed, both platelet-rich plasma and surgical interventions have their effective 
characteristics for the management of rotator cuff tendinopathies. Platelet-rich plasma promotes 
healing and growth factors to the area of injury allowing for tissue to regenerate. Surgery 
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provides the true intervention to physically manage the injury and correct the abnormality. When 
a tear is present, surgery tends to be the course of action after nonsurgical interventions have not 
been effective. The thought here is that when combining surgical interventions and then 
implementing PRP injections post-operation, PRP can promote healing and strengthening of the 
rotator cuff more rapidly allowing for greater long-term outcomes associated with pain and 
functionality. 
In the American Journal of Sports Medicine, Malavolta et al conducted a randomized 
control study to evaluate the 5-year outcomes of patients who received surgery to repair their 
torn rotator cuff with and without the addition of platelet-rich plasma.17 The 51 patients included 
in the study had small to medium tears to the supraspinatus that were required to be confirmed 
by MRI and have no history of retraction and were all surgically repaired by the same surgeon. If 
there were other tears, fatty degeneration, glenohumeral arthrosis, previous surgery, 
rheumatological diseases, fibromyalgia, or platelet counts less than 150,000/mm3 patients were 
excluded from the study. The study was focused on performing a functional assessment of the 
shoulder using the UCLA shoulder rating scale and Constant shoulder scale, used the Visual 
Analogue Scale (VAS) for pain, and MRI to assess rate of retear. There were 26 patients in the 
PRP group with 25 in the control group. All patients participated in the same rehabilitation 
programs including NSAIDs and immobilization initially for 6 weeks, active-assisted and active-
free exercises from weeks 6-12, and muscle strengthening after week 12. Patients were evaluated 
at 3, 6, 12, 24, and 60-months post-operation. The mainstay of this study was to determine the 5-
year outcomes compared to baseline and after statistical analysis.  
It was concluded that there was no significant differences between the PRP group and the 
control group. Using the UCLA scores, the mean preoperative scores were 13.6 with a standard 
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deviation of 3.8 for the control group and 14.2 with a standard deviation of 4.6 for the PRP 
group.17 When reevaluated at the 60-month mark, the mean scores were 32.5 with a standard 
deviation of 3.8 and 32.1 with a standard deviation of 4.6 respectively.17 The VAS scores for 
pain also reported no major differences with the preoperative or postoperative scores. 
Preoperative evaluations were 6.9 with a standard deviation of 1.9 for the control and 6.6 with a 
standard deviation of 1.6 for the PRP group. Postoperative evaluations were 82.0 with a standard 
deviation of 9.5 and 82.1 with a standard deviation of 11.0 respectively.17 MRI evaluations also 
reported no significant differences. Even with no significant findings, it was vital for 
comparative purposes that this study includes surgical interventions, traditional nonsurgical 
interventions in rehabilitation, and the inclusion of PRP. 
The Journal of Orthopaedic Surgery and Research published a study by Mao et al 
conducting a study that also supports the previous findings by Malvolta et al. The main 
difference between the two studies were volume of patients evaluated and time in which patients 
had follow-up. This meta-analysis used a total of 8 studies including 219 patients where PRP was 
used against a control to determine if it would improve outcomes within 12-27 months and 
reduce the rate of retears. Using the ASES, UCLA scale, and Constant score for patient 
functional outcomes, they did not note any significant differences in the control groups compared 
to the PRP groups.18 Of the 8 studies, 7 evaluated the retear rate in which the results were 
consistent throughout and not presenting an alarming retear rate from one group to the other. 
Four of the studies used ASES scores showing a weighted mean difference of -1.25, 95% CI of -
2.58 to 0.08, and a P = 0.066 showing no significant clinical differences either.18 The two studies 
that used the UCLA score showed a weighted mean difference of -0.97, 95% CI of -2.56 to 0.62, 
and a P = 0.230 again showing no major differences.18 And the four studies that used the 
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constant score were very similar: a weighted mean difference of -0.73, 95% CI of -1.30 to 2.77, 
and a P = 0.481.18 With it being a larger sample size, it is important to note that this evidence 
does help support that case the PRP does not include any additional benefits in the process of 
healing after arthroscopic rotator cuff surgery. One limitation with this being a meta-analysis 
compared to Malvolta et al is that they had all of their participants from the same surgeon and on 
the same rehabilitation regimen as well keeping data more reliable regardless if this data shows 
similar trends. 
On the contrary to the previous two articles, the Journal of Orthopaedic Surgery and 
Research published a meta-analysis study of randomized control trials performed by Han et al 
showed differing results. This study similarly focused on indicating whether or not the use of 
PRP in conjunction with surgery will improve functional outcomes and decrease the likelihood 
of retear within a timeline of 6-16 months.19 Though very similar in structure by again using the 
Constant score, UCLA score, and simple shoulder test score for functionality and possibility of 
retear, the results differed. This meta-analysis evaluated 13 randomized control trials for patients 
who received a combination of both single row and double row rotator cuff repairs. Of the 12 
that reported retear rate, retears occurred in 63 of 392 patients (or 16%) for the patient group 
which received the PRP treatment whereas there were 90 of 381 patients (or 24%) for the control 
groups.19 The integrity of the repair was determined by MRI, CT, or ultrasound. The Constant 
score was also used in 9 studies for 615 patients and suggested that rotator cuff improvement 
post-operation could be accelerated with the PRP. The mean difference was 2.31, 95% CI was 
1.02-3.61, and P = 0.0005.19 The UCLA score and ASES were also shown to be significantly 
higher in the PRP groups compared to the controls in the 7 studies they were incorporated in. It 
was also important to note that 5 of the studies used VAS for pain where the PRP groups 
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reported lower pain scores with a mean difference of -0.35 and a 95% CI of -0.57 to -0.13.19 The 
theory behind this study is that PRP enhances growth factors to promote healing as previously 
reported. Interestingly enough, the results differ from other studies conducting meta-analysis as 
well. 
In an article published by Nature Research, Fang et al performed a meta-analysis of 
randomized control trials to determine if applying PRP during arthroscopic rotator cuff repairs of 
full-thickness rotator cuff tears would impact retear rate and functional outcomes. What was 
interesting about this meta-analysis is that it actually indicated that a couple of the previous 
studies displayed contradicting results. Mao et al, as previously stated, noted that there were no 
significant differences in the PRP group vs the control group when it came to surgical outcomes 
with the implementation of PRP. In the Han et al study, they reported the opposite stating that 
the PRP group displayed better outcomes than the group that did not receive PRP post-operation. 
By acknowledging the conflicting results, the Yang et al meta-analysis selected varying studies 
with similar structures to the other two. By doing so, they were able to follow the same 
methodologies with different patient pools to develop their own findings giving a well-rounded 
comprehensive approach to determine if PRP truly does have an impact on post-operative 
outcomes for rotator cuff repairs.  
In total, 7 studies were used with 273 patients in the PRP group with 268 in the control 
group. Patient diagnosis of a tear was required to be confirmed by MRI and the longest follow-
up for ranged from 12-60 months. After assessing retear rate to determine the structural integrity 
of the rotator cuff, Constant score and UCLA score for functionality, and VAS for pain, the 
results were quite interesting. Retear rate was significantly lower in the PRP group with 
RR=0.38, 95% CI (0.22,0.68), P=0.0009).20 Regarding Constant score, only the short term 
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showed a minimally better score for the PRP group, but the long term gave similar statistics. The 
UCLA showed significantly higher scores in the short term for the PRP group but again no 
significant differences in the long-term like the Constant.20 As for the VAS assessing pain, there 
were slight differences in the short-term favoring the PRP group but no major differences to note 
for the long-term.20 Refer to table 4 for the statistical differences.20 According to these findings, 
incorporating PRP for post-operative management of these rotator cuff surgery patients shows 
benefits in their short-term recovery time regarding pain and functionality and also show 
improvements in retear rate. All are important to note to improve overall outcomes of these 
procedures to decrease the number of cases in the future. 
Methods: 
This research was conducted with the use of Google Scholar, PubMed, and ScienceDirect 
by performing a systematic database search for peer-reviewed articles of significant relevance to 
the topic at hand. During the search, articles were originally selected within the range of 2018 to 
present to have the most up-to-date information regarding rotator cuff tendinopathies. As the 
search continued for clinically relevant data, additional articles were sourced from articles 
themselves. After the search was conducted, 20 articles were pulled to develop an all-
encompassing clinical review comparing traditional surgical and nonsurgical interventions to 
platelet-rich plasma injections in improving long-term outcomes for patients with rotator cuff 
tendinopathies. While conducting the search, keywords and phrases such as “rotator cuff 
anatomy”, “biomechanics rotator cuff tendinopathies”, “rotator cuff surgery”, “rotator cuff non 
surgical”, “rotator cuff PRP”, “rotator cuff treatments”, “rotator cuff tendinopathies”, and 
“double row” were highly utilized and yielded the best results. In order to understand the rotator 
cuff and mechanisms of injury further, CURRENT Medical Diagnosis & Treatment was also 
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utilized. The textbook provided an anatomical foundation as well an understanding for how the 
rotator cuff is injured. 
Discussion: 
With rotator cuff tendinopathies continuing to be a growing problem, it is important for 
medical providers and populations alike to understand the causes, interventions, and proper 
methods of management to provide the best outcomes to patients. Conflicting findings continue 
to make it difficult to entirely understand which is the best for long-term outcomes for these 
patients. The newest intervention attempting to make a breakthrough is the use of platelet-rich 
plasma injections. PRP in simple terms is essentially a high concentration of plasma to promote 
an influx of growth factors to enhance the healing process. The idea is for long-term success for 
these patients to have an improvement in pain, functionality, range of motion, and integrity to 
prevent future tears of the shoulder. Physicians have been experimenting with PRP 
preoperatively as an alternative to traditional nonsurgical managements such as corticosteroids, 
physical therapy, NSAIDs, and nerve blocks/ablations. It has also been used postoperatively to 
enhance the healing process and improve the integrity of the damaged tissue. Studies seem to 
have results not consistent with one another which seems to be the outstanding problem. 
Preoperative management of rotator cuff tendinopathies has traditionally centered around 
the use of corticosteroids, NSAIDs, physical therapy, and nerve blocks/ablations in serious cases 
when surgery is contraindicated. Each method has proven to have their benefits on pain, healing, 
functionality, and strengthening all which are key points to focus on when treating the patient. 
Physical therapy has shown success rates regarding strengthening and functionality in upwards 
of 75-91% of patients. With corticosteroids and NSAIDs, they both do benefit the patient in the 
short-term regarding the patient's VAS pain assessment as they are meant to decrease 
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inflammation but compared to a placebo control there were no significant findings for the long-
term outcomes. Due to these results, comparative studies have come to the table comparing PRP 
interventions to interventions such as corticosteroids and physical therapy. Ibrahim et al 
determined that when assessing ROM, functionality, and VAS for pain, corticosteroids and PRP 
both provided similar results not indicating one as being superior to the other. The one difference 
that was noted was PRP promoted better healing according to ultrasound leading to a lesser 
likelihood of retear and further injury. But in other similar studies, it was shown that the VAS 
and ROM were significantly improved compared to the corticosteroid group. When comparing 
the PRP group to a physical therapy group, findings also varied from study to study. For 
example, the Kim et al study provided data that was able to show PRP improved functionality of 
the shoulder at 24 weeks but the Lin et al study contradicted those findings and did not provide 
any significant differences between PRP and physical therapy. There just seemed to be too many 
contradicting factors in these studies comparing PRP to traditional nonsurgical interventions 
which does not entirely support one over the other. But one thing to note is that none of the 
studies encountered provided data showing PRP being a worse nonsurgical intervention for 
rotator cuff tendinopathies. 
For patients that fail nonsurgical interventions and are required to undergo arthroscopic 
surgery to repair the rotator cuff, the main goal is to get the patient back to their preoperative 
state or better. Again, this comes down to pain, functionality, range of motion, strength, and 
likelihood for retear. What physicians have begun doing is providing patients with PRP 
injections post-operation to, in theory, promote healing so the patients can get back to full health 
more rapidly. But the importance of the possibility of more rapid healing needs to align with the 
importance of reducing the chances of retearing the rotator cuff. The studies conducted to 
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compare primarily used a PRP group and then a control group that did not receive PRP. In most 
studies, it was reported that these patients also participated in physical therapy programs to 
improve strengthening and functionality of the shoulder. The most extensive study conducted by 
Malavolta et al followed patients for 5 years and did not show any significant differences 
between the PRP and non-PRP groups. A subsequent study performed by Mao et al provided 
similar results as they also did not note any notable findings to support one group vs. another. 
But contradictory to both of those studies, two meta-analyses’ conducted by Han et al and Fang 
et al provided data to show that the PRP group differed from the control. There was evidence 
associated with the likelihood of retear showing only 16% for those who received PRP compared 
to 24% for those who did not. There was also support showing reduced VAS for pain and 
improved ASES and UCLA scores for functionality. The support indicating the benefits of PRP 
for postoperative management of rotator cuff tears is encouraging, but at the same time difficult 
to draw a definitive method for management due to the conflicting studies structured in very 
similar ways. With more research, fundamental studies, and patient cooperation for those 
involved in these studies, there will be advances and allow for these patients to have improved 
outcomes.  
The information found in the studies comparing surgical interventions, traditional 
nonsurgical interventions, and platelet-rich plasma injections creates less clarity than preferred. 
The monotherapy of each provided benefit as depicted in all studies, but the lack of consistency 
regarding which is the superior intervention made this difficult to actually assess. Multiple 
studies stated that PRP would be more beneficial as a monotherapy when compared to traditional 
nonsurgical interventions. But alternative studies stated that there was no difference between one 
versus another. Similarly, PRP was viewed to be more beneficial when used in conjunction with 
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arthroplasty double row rotator cuff tear repair for the long-term outcomes regarding patient’s 
pain, range of motion, and functionality. But, again, there were studies contradicting those 
findings stating that there was no difference between the PRP group and the control. What is 
known up to this point is that all of these interventions are helpful in the long-term outcomes of 
these patients. Without the consistency of the evidence throughout these studies, one can only 
continue to hypothesize that a combination of all three will reign superior to monotherapy. 
Incorporating physical therapy, PRP, and surgery if a tear is present seems like a viable option to 
manage these patients and have the best outcomes. Combining these studies suggests evidence 
that this would be beneficial but the study needs to actually be conducted while maintaining 
patient enrollment to get a true assessment. 
All of these studies contained their limitations possibly inhibiting the validity of the 
results. In the individual studies, sample size was a common trend observed. With smaller groups 
of patients, they were not able to properly acquire sufficient data regarding retear rate and there 
was also a higher than desired dropout rate. In order to have more valid data, the sample size 
needed to be substantially larger and maintain through the entire studies. It was also difficult to 
determine initial tear size and limitations because multiple meta-analyses were used and there 
was no access to some of the patient’s true baseline. When not having access to the initial tear 
information, it makes it much more difficult to determine if the patient may be susceptible 
further injury and also retear. One final limitation that is quite common is the fact that pain is 
very subjective and difficult to measure. Filling out the questionnaires to determine how the 
patient is progressing is good, but it does not necessarily provide the information on healing as 
some patients may present with greater pain tolerance than others. In order for these studies to 
continue working toward providing validity for the treatment methods for rotator cuff 
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tendinopathies, there is an importance in maintaining a large sample size, gain access to entire 
patient profiles, monitoring lifestyle and activity after treatment, and continue to develop 
methods to assess for pain, range of motion and functionality in as minimally subjective ways 
possible. It is also quite difficult to entirely monitor post-intervention lifestyle choices and 
medication use allowing for discrepancies in outcomes. 
Conclusion: 
Rotator cuff tendinopathies will continue to be a problem that medical providers will 
encounter and the best interventions for patient outcomes need to be understood. The prevalence 
of these injuries remains high due to the anatomical makeup and excessive daily involvement of 
the shoulder as well as factors reducing the structural integrity such as age. As shown, an age 
greater than 50, diabetes, and overhead activities are the major contributors to these injuries and 
none of these are going away. Regarding the implementation of platelet-rich plasma, the question 
remains if it is more beneficial compared to traditional surgical and nonsurgical interventions for 
long-term outcomes regarding pain, range of motion and functionality. It has definitely shown its 
benefits in implementation prior to surgery and post-surgery. It has even provided evidence that 
it promotes better healing in the short term, greater reduction of pain, and improved functionality 
and range of motion than traditional nonsurgical interventions used to manage rotator cuff 
tendinopathies before and after surgery. The issue that seems to continue surface is the lack of 
consistent evidence. Prior to surgery, PRP did not always outperform traditional nonsurgical 
interventions. And postoperatively, studies were able to display evidence that supported no 
significant differences between receiving PRP and placebo. More research needs to be done to 
entirely support the idea that platelet-rich plasma is the superior to options such as 
corticosteroids, physical therapy, and NSAIDs prior to surgery and the specific need for it to 
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enhance long-term outcomes by implementing it post-surgery. Pain, range of motion, and 
functionality are all key contributors to a patient’s long-term success, which all need to continue 
to be monitored and adjusted for all patients suffering from rotator cuff tendinopathies. 
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